Genetic Epidemiology of Adult Onset Glioma

Adult-Onset Glioma Clinical Trial

Official title:

Genetic Epidemiology of Adult-Onset Glioma

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00283569
• Other study ID #: mrbt1-03-132
• Secondary ID: MRBTC2003-01
• Status: Completed
• Phase: N/A
• First received: January 26, 2006
• Last updated: January 18, 2010
• Start date: May 2004
• Est. completion date: January 2010

Study information

• Verified date: January 2010
• Source: Kentuckiana Cancer Institute
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

To establish a clinic based case control study for examination of potential risk factors for primary adult brain tumors.

Description:

Genetic epidemiology of adult glioma to establish potential risk factors for primary adult brain tumors.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: January 2010
• Est. primary completion date: January 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• primary glioma of any stage

• diagnosed within 4 months

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Adult-Onset Glioma
• Glioma

Intervention

Other:
• Mouth Swab, Toe Nail Clippings, Questionnaires
The objective of this study is to establish a clinic based case control study for examination of potential risk factors for primary adult brain tumors.

Locations

Country	Name	City	State
United States	Kentuckiana Cancer Institute	Louisville	Kentucky

Sponsors (2)

Lead Sponsor	Collaborator
Kentuckiana Cancer Institute	DR. Kathleen Egan

Country where clinical trial is conducted

United States,